By increasing the number of docking sites for growth hormone on the surface of these cells, BPC-157 helps them multiply faster when growth hormone is present
Dynamis Online is not a pharmacy and does not manufacture, distribute, or ship any medications discussed on this site
BPC-157 tackles this problem directly by: Stimulating neoangiogenesis within the tendon or ligament substance Activating tenocytes (tendon cells) to produce organized collagen Reducing fibrotic adhesion formation that limits range of motion Condition-by-Condition Clinical Applications Tendinopathies Chronic tendon conditionsAchilles, patellar, rotator cuff, lateral epicondyle (tennis elbow), medial epicondyle (golfers elbow)respond exceptionally well to BPC-157
Future development must directly address these concerns
Reconstitution: 3.0 mL bacteriostatic water per 10 mg vial gives ~3.33 mg/mL for accurate unit measurements
Liver and kidney markers are reasonable to track in extended high-dose protocols